These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 23163959)

  • 1. Olopatadine versus levocetirizine in chronic urticaria: an observer-blind, randomized, controlled trial of effectiveness and safety.
    Sil A; Tripathi SK; Chaudhuri A; Das NK; Hazra A; Bagchi C; Islam CN
    J Dermatolog Treat; 2013 Dec; 24(6):466-72. PubMed ID: 23163959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and safety of levocetirizine 10 mg versus a combination of levocetirizine 5 mg and montelukast 10 mg in chronic urticaria resistant to levocetirizine 5 mg: A double-blind, randomized, controlled trial.
    Sarkar TK; Sil A; Pal S; Ghosh C; Das NK
    Indian J Dermatol Venereol Leprol; 2017; 83(5):561-568. PubMed ID: 28656910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the antihistamine effects of olopatadine and levocetirizine during a 24-h period: a double-blind, randomized, cross-over, placebo-controlled comparison in skin responses induced by histamine iontophoresis.
    Takeo T; Kasugai C; Tanaka R; Ando T; Ogawa A; Akita Y; Watanabe D
    J Dermatol; 2013 Dec; 40(12):987-92. PubMed ID: 24303975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Night-time sedating H1 -antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial.
    Staevska M; Gugutkova M; Lazarova C; Kralimarkova T; Dimitrov V; Zuberbier T; Church MK; Popov TA
    Br J Dermatol; 2014 Jul; 171(1):148-54. PubMed ID: 24472058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levocetirizine and rupatadine in chronic idiopathic urticaria.
    Johnson M; Kwatra G; Badyal DK; Thomas EA
    Int J Dermatol; 2015 Oct; 54(10):1199-204. PubMed ID: 25521304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the efficacy of olopatadine and fexofenadine in chronic idiopathic urticaria patients: a crossover study.
    Tanizaki H; Yamamoto Y; Nakamizo S; Otsuka A; Miyachi Y; Kabashima K
    Pharmacology; 2015; 95(1-2):32-5. PubMed ID: 25592003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study.
    Zuberbier T; Oanta A; Bogacka E; Medina I; Wesel F; Uhl P; Antépara I; Jáuregui I; Valiente R;
    Allergy; 2010 Apr; 65(4):516-28. PubMed ID: 19860762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study.
    Nettis E; Colanardi MC; Barra L; Ferrannini A; Vacca A; Tursi A
    Br J Dermatol; 2006 Mar; 154(3):533-8. PubMed ID: 16445787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study.
    Kapp A; Pichler WJ
    Int J Dermatol; 2006 Apr; 45(4):469-74. PubMed ID: 16650180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double dose of cetirizine hydrochloride is effective for patients with urticaria resistant: a prospective, randomized, non-blinded, comparative clinical study and assessment of quality of life.
    Okubo Y; Shigoka Y; Yamazaki M; Tsuboi R
    J Dermatolog Treat; 2013 Apr; 24(2):153-60. PubMed ID: 21810005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy of cetirizine and levocetirizine in chronic idiopathic urticaria.
    Garg G; Thami GP
    J Dermatolog Treat; 2007; 18(1):23-4. PubMed ID: 17365263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical effectiveness and safety of cetirizine versus rupatadine in chronic spontaneous urticaria: a randomized, double-blind, 6-week trial.
    Dakhale GN; Shinde AT; Mahatme MS; Hiware SK; Mishra DB; Mukhi JI; Salve AM
    Int J Dermatol; 2014 May; 53(5):643-9. PubMed ID: 24320728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of single therapeutic doses of promethazine, fexofenadine and olopatadine on psychomotor function and histamine-induced wheal- and flare-responses: a randomized double-blind, placebo-controlled study in healthy volunteers.
    Kamei H; Isaji A; Noda Y; Ishikawa K; Senzaki K; Yamada K; Sugiura K; Tomita Y; Nabeshima T
    Arch Dermatol Res; 2012 May; 304(4):263-72. PubMed ID: 22130869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open-label prospective clinical study to assess the efficacy of increasing levocetirizine dose up to four times in chronic spontaneous urticaria not controlled with standard dose.
    Sharma VK; Gupta V; Pathak M; Ramam M
    J Dermatolog Treat; 2017 Sep; 28(6):539-543. PubMed ID: 27779432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
    Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A
    Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients.
    Potter PC; Kapp A; Maurer M; Guillet G; Jian AM; Hauptmann P; Finlay AY
    Allergy; 2009 Apr; 64(4):596-604. PubMed ID: 19053988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levocetirizine and Prednisone Are Not Superior to Levocetirizine Alone for the Treatment of Acute Urticaria: A Randomized Double-Blind Clinical Trial.
    Barniol C; Dehours E; Mallet J; Houze-Cerfon CH; Lauque D; Charpentier S
    Ann Emerg Med; 2018 Jan; 71(1):125-131.e1. PubMed ID: 28476259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levocetirizine for chronic idiopathic urticaria: a review.
    Ducharme EE; Weinberg JM
    J Drugs Dermatol; 2009 Mar; 8(3):243-7. PubMed ID: 19271371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open-label, multicentre study of levocetirizine for the treatment of allergic rhinitis and urticaria in Taiwanese patients.
    Fang SY; Perng DW; Lee JY; Lin DY; Huangs CY
    Chin J Physiol; 2010 Aug; 53(4):199-207. PubMed ID: 21793329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for clinical safety, efficacy, and parent and physician perceptions of levocetirizine for the treatment of children with allergic disease.
    Pampura AN; Papadopoulos NG; Spičák V; Kurzawa R
    Int Arch Allergy Immunol; 2011; 155(4):367-78. PubMed ID: 21346367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.